This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2018-04-10 BR&R Conf Call"

From HL7Wiki
Jump to navigation Jump to search
Line 47: Line 47:
 
* Ed Helton will not be able to attend.
 
* Ed Helton will not be able to attend.
 
WGM discussion:
 
WGM discussion:
Need 1 quarter for BRIDG ballot reconciliation (Wednesday?)
+
* Need 1 quarter for BRIDG ballot reconciliation (Wednesday?)
Need 1 quarter for Lab Model(Wednesday?)
+
* Need 1 quarter for Lab Model(Wednesday?)
Hugh suggested finding time to discuss use cases.
+
* Hugh suggested finding time to discuss use cases.
Smita suggested talking about activities or mapping.
+
* Smita suggested talking about activities or mapping.
 
Boris previously recommended a quarter for Regulations.
 
Boris previously recommended a quarter for Regulations.
Rik Smithies previously recommended a quarter on IDMP resources
+
* Rik Smithies previously recommended a quarter on IDMP resources
Jean Duteau recommended time for Medication and Adverse event
+
* Jean Duteau recommended time for Medication and Adverse event
 +
* Julie Evans Recommended Research subject. Perhaps this could be discussed during the BRIDG lab reconciliation.
  
 
===3. PSS Review and Approval===
 
===3. PSS Review and Approval===

Revision as of 15:48, 10 April 2018

Attendees

  • Ed Helton (Chair)
  • Hugh Glover (Chair)
  • Myron Finseth (Chair, scribe)
  • Julia Chen
  • Ginny Hussong
  • Jean Duteau
  • Julie Evans
  • Bill Friggle
  • Norman Gregory
  • Smita Hastak
  • Wendy Ver Hoef
  • Ulli Wagner
  • Catherine Hosage Norman
  • Robinette Renner
  • Jim Rogers

Agenda Items and notes

1. Minutes Approval

Minutes from conference call 27th March approved. Jim Rogers motioned; Julie Evans second

2. May WGM Agenda

Draft is at wc 2018-05-14 BR&R WG Meeting

  • Ed Helton will not be able to attend.

WGM discussion:

  • Need 1 quarter for BRIDG ballot reconciliation (Wednesday?)
  • Need 1 quarter for Lab Model(Wednesday?)
  • Hugh suggested finding time to discuss use cases.
  • Smita suggested talking about activities or mapping.

Boris previously recommended a quarter for Regulations.

  • Rik Smithies previously recommended a quarter on IDMP resources
  • Jean Duteau recommended time for Medication and Adverse event
  • Julie Evans Recommended Research subject. Perhaps this could be discussed during the BRIDG lab reconciliation.

3. PSS Review and Approval

3.1

4. FHIR

4.1 FHIR Tracker Items

  • Tracker 14314. De-identification of patients within the ResearchSubject resource. Contact Hugo Leroux(Julie Evans)

4.2 IDMP Related Models

  • Closure of PSS #1338 and draft a new one (Boris Brodsky)

4.3 Lab model in conjunction with Transcelerate

  • Any progress?

4.4 Medication and Device Information

  • Possible new initiative (Boris Brodsky)

4.5 Clinicians on FHIR

  • ClinFHIR demonstration (Hugh Glover)

http://clinfhir.com/

4.6 Oncology use of AE Resource

  • FDA expression of interest (Boris Brodsky)

5. Action Item List

  • Nothing at this time

6. AOB

  •  ???